SlideShare a Scribd company logo
HYPERTENSIVE DISORDERS IN
PREGNANCY
GIRMACHEW T.(MD)
OBGY
MAY 22, 2018
GONDAR, ETHIOPIA
Outline
Diagnosis of HTN
Introduction
Classification
Pathophysiology and risk factor
Clinical presentation
Management
Introduction
 Most common medical complication
 Incidence 7-10% all pregnancies
70 % Preeclampsia- Eclampsia
30 % Chronic HTN
0.05 Eclamosia
 Major cause of maternal and perinatal mortality &
morbidity.
Classification
1) Gestational HTN( transient HTN)
2) Preeclampsia- Eclampsia syndrome
3) Chronic HTN
4) Preeclampsia superimposed on chronic HTN
Diagnosis
Hypertension:
Systolic BP > 140 or DBP > 90 mmHg. Measured
on any two occasions > 6hrs apart
or
One DBP> 110 mmHg
Proteinuria
Urine protein > 300mg/24hr or
30mg/dl(1+dipstick) or 0.1gm/L in at least two
random urine sample
Urine protein : creatinine ratio > 0.3
Edema No longer part of diagnosis
* wt gain >1kg/ week & pathological edema are↑
warning sign
Gestational Hypertension
Definition
B/P > 140/90 mmHg for first time during pregnancy
after 20 wks G.A or first 24 hrs post partum.
 No proteinuia
 Mild HPN & must return with in 12 weeks postpartum
 It is a diagnosis of exclusion
 Final dx made only postpartum.
Pregnancy outcome similar to normotensive pregn
 At risk of progression to PE or eclampsia
 Close observation of maternal & fetal condition
 In absence of severe HPN or PE can continue
pregnancy till term
Preeclampsia
Definition
 new onset of hypertension after 20 weeks of
gestation and
1. Proteinuria
2.Trombocytopenia(<100,000/ml)
3.Renal insuficiency….cr>1.2 mg/dl or doubling of base
line
4.Liver involvement….transaminase elivation
5.Cerebral symptoms…headache, visual disturbance,
convulsion
6.Pulmonary edema
 pregnancy specific syndrome of reduced organ
perfusion secondary to vasospasm and endothelial
activation.
incidence nullipara = 3-7% multipara 0.8-5%
Superimposed upon chronic HTN
HTN and no proteinuria <20 weeks:
 New onset proteinuria after 20 weeks of GA
HTN and protienuria <20 weeks:
Sudden increase in proteinuria
Sudden increase in BP in woman whose BP was well
controlled
Thrombocytopenia ( <100,000/ml)
Increase in ALT or AST to abnormal levels
Chronic HTN
BP > 140/90 mmhg before px or diagnosed before
20 weeks of GA or diagnosed after 20 weeks of GA
and persists after 12 weeks postpartum
Other associated findings
 Retinal change
 Cardiac
 Renal diseaese
 Other medical illness
Risk factors for PE
• Nulliparity
• Obesity
• Age <20 or > 35 yrs(chronic HTN and superimposed
PE)
• Multiple gestation
• Low socioeconomic status
• GTD
• Poor outcome of previous pregnancy (IUGR, SB
,abruption)
• ART( assisted reproductive technology)
• Race , ethinicity, genetics
Pre-existing medical conditions
 Chronic HTN
 Renal disease
 DM (type I)
 Thrombophilias (APA, protein C,S deficiency )
Smoking is it a risk factor or protective?
Classification of PE
Non severe PE Severe PE
BP >160/110 mmhg
Proteinuria of >5g/24 hr
Oliguria <500ml/24 hrs
Thrombocytopenia
Elivated liver function test with
persistent epigastric or RUQ pain
Pulmonary edema
Persistent severe cerebral or visual
disturbances
Convulsion
HELLP syndrome and DIC
BP >140/90
mmhg
Proteinuria of
300mg/ 24 hrs or
1+ on dipstich
Etiology & pathogenesis
Etiology – Unknown
Known as disease of theory
Some of theories
• Abnormal trophoblast invasion
Coagulation Abnormalties
Vascular endothelial damage
Immunologic theory
Placental toxin theory……toxemia of pregnancy
Genetic predisposition
Dietary deficiencies ….calcium and antioxidant
deficiencies
Any theory has the following charactersitics
1. Exposed to chorionic villi for the first
time….nulliparous
2.Exposed to superabundance of chorionic villi…twins
and GTD
3.Preexisting condition of endothelial cell
activation/inflammation….DM/renal/
cardiovascular disease
4.Genetically predisposed to HTN developing during
pregnancy…family hx
Abnormal Trophoblast invasion
Defective vascular response to placentation due to
inhibition of 2nd wave of endovascular trophoblast
occur often 16 week
Trophoblastic invasion of spiral arterioles leads to
the destruction of the muscularis layer which is
replaced by trophoblastic cells which do not
respond to the autonomic stimulation of blood
vessels; this ensures that there is a constant
uninterrupted blood flow to the intervillous space
According to the immunological theory, there is sufficient
similarity between paternal and maternal HLA antigens,
which prevents early fetal antigens from detection by the
maternal immune system
This leads to failure of production of blocking antibodies
early in gestation
As fetal antigens increase in amount later in gestation, the
maternal immune system responds by producing antibodies
that destroy placental trophoblasts
SYSTEMIC ENDOTHELIAL
DYSFUNCTION
All of the clinical features of preeclampsia can be
explained as maternal responses to generalized
endothelial dysfunction
Disturbed endothelial control of vascular tone causes
hypertension, increased vascular permeability results
in edema and proteinuria, and abnormal endothelial
expression of procoagulants leads to coagulopathy.
These changes also cause ischemia of target organs,
such as the brain, liver, kidney, and placenta.
Laboratory evidence supporting generalized
endothelial dysfunction in preeclamptic women
- Decreased production of endothelial-derived
vasodilators -nitric oxide and prostacyclin
- increased production of vasoconstrictors -endothelins
and thromboxanes.
- Enhanced vascular reactivity to angiotensin II
Organ
system
Pathology complication
CVS Generalized vasospasm; increased
afterload; left ventricular strain and
failure; microvascular endothelial
damage and fluid and protein leakage
•Hypertension
•Congestive heart failure
•Generalized edema
•Pulmonary edema
Hematolog
ic
Excessive consumption of platelets to
repair endothelial damage; RBC
damage as they pass through the
spastic arterioles
•Thrombocytopenia
•Microangiopathic
hemolytic anemia
Renal Decreased glomerular filtration rate
due to spasm; renal glomerulo
endotheliosis; renal tubular necrosis;
renal cortical necrosis in advanced
•Acute renal failure
•Proteinuria
•Hyperuricemia
Respirator
y
Pulmonary capillary endothelial
damage and leakage ( in addition to
hypoproteinemia due to proteinuria
and left ventricular failure)
Pulmonary edema
Organ
system
pathology complication
Gastrointes
tinal
Hepatocellular injury distal to vascular
spasm site; focal hemorrhages distal to
spasm site; coalescing focal
hemorrhages leading to large hematoma
collection under the Glisson’s capsule
•Hepatic failure
•Sub capsular hematoma
•Acute liver rupture
CNS Cerebral hypoxia due to vasospasm;
focal hemorrhages distal to the
vasospasm; secondary cerebral edema;
intracranial hemorrhages
•Eclampsia
•Hemorrhagic stroke
•Cerebral edema and
death due to coning
•Transient blindness –
retinal or cortical
HELLP
syndrome
Concomitant occurrence of
microangiopathic hemolysis;
thrombocytopenia and liver damage
features in a woman with preeclampsia
system pathology complication
Blood volume Due to generalized vasospasm,
there is contracture of the total
vascular space. The normal
increase in blood volume that
occurs during normal pregnancy
fails in preeclampsia. They tend
to have a contracted and overall
reduced blood volume
•Less tolerant to blood
loss at delivery with an
easy propensity to post
partum hemmorhage
with small amount of
blood loss
•Less tolerant to fluid
administration with a
propensity to develop
pulmonary edema
symptoms sign Diagnostic study
•Non severe preeclampsia
is asymptomatic
•Symptoms are late
features indicating severe
disease or imminent risk of
convulsions
•These symptoms include
headache, blurring of
vision, epigastric pain,
oliguria and generalized
body swelling
•Hypertension
•Generalized
edema/anasarca
•Excessive weight gain
•Exaggerated deep
tendon reflexes
•Proteinuria
•24 hour urine for
proteinuria
•Liver and renal function
tests
•Hematocrit
•Peripheral blood smear
for shistocytes
(fragmented RBC)
•Platelet count
•Serum uric acid
measurement
•Fetal well being studies
As preeclampsia is asymptomatic until it progresses to severe stages, detection
and diagnosis requires active screening of all pregnant women during antenatal
care. Routine blood pressure measurements, weight gain surveillance and check
for symptoms and proteinuria are performed to detect preeclampsia early.
Management
Objective
Preserve health of mother & fetus
Prevent progression to eclampsia
Delivery of alive, mature fetus
* Once Dx is made definitive Rx is delivery
* Precise Knowledge G.A Important for Mx.
Mx of Non severe PE
Hospitalization  at time of Dx
Purpose Evaluate maternal & fetal condition
Hospital Mx
Maternal follow up
 Weight on admn. & every other day
 B/P  Q 4 hrly
 Daily clinical Hx premonitory Sx
 Urine protein every 48 hrs
Hct, Plc, RFT, LFT, uric Acid, coagulation profile
weekly or 2x/week.
Fetal evaluation
Daily FHR Auscultation & fetal mov’t count
Fetal growth: clinical & U/Sound
Well being NST/BPP (2x/week)
**Non sevre PE remote from term delivery at term
but pregnancy should not pass 40 weeks.
** no need of antihypertensive or seizure prophylaxix
Mx of severe PE
characterized by progressive deterioration of both
maternal & fetal condition
 All should be delivered if disease develope >34 week
G.A or prior to 34 weeks if there is
- Maternal (Fetal) distress
- Labor or PROM
- Severe IUGR
**Delivery should be based on maternal and fetal
conditions as well as GA
Mx of severe PE includes
Maternal & fetal evaluation same Non PE but more
frequent.
Anticonvulsant to prevent convulsion
Antihypertensive To control B/P in safe range
Induction of labor Delivery
 Admit to labor & delivery area.
 Then Maternal & fetal evaluation 1st 24 hr
 Anti-convulsant  parenteral route To prevent seizure
Indication
Anti- convulsant drugs
 Mg so4
 Diazepam

Phenytoin
Antepartum mg't of severe PE
Magnesium Sulfate (Mg So4)
Mg so4
Agent of choice for seizure prophylaxis
Dose: loading dose 4gm 20%soln  over 10-15min
followed by 10 g of 50% solution half on each buttock
maintenance dose: 5gmI.M/4 hr
Make sure the following before giving next dose
1. Patellar reflex is present
2.RR at least 16 breaths/min
3. UOP of previous 4 hr exceeded 100 ml
Side effect: Weakness, paralysis, cardiac toxicity
Monitor: RR, DTR,Level of consciousness, UOP
Antidote: Calcium gluconate 10 ml of 10% I.V
MgSO4 level (mg/dl)
4.8- 8.4
8- 10
12 -17
13- 17
19 -20
Effects
Therapeutic level
Loss of DTR
Respiratory depression
CNS depression, coma
Cardiac arrest
Clinical effects are related directly to plasma
levels
Antihypertensive
 If DBP > 110 mmHg
Acute Rx
Arteriolar dilators – Hydralazine 5mg iv then 5-10mg
Q 20min.
B- Blocker – labetalol
Ca channel blocker – nifedipine
Maintenance Rx
Centrally acting  Methyl dopa
B- Blockers- labetalol
Ca channel Blocker -nefidipine
ACE inhibitors C/I in pregnancy
Delivery
PE progressive disease
Timely delivery  decreases maternal and fetal
morbidity& mortality
Stabilize maternal status before Delivery
Route of delivery…vaginal delivery is
preferable
Indication to Delivery in PE
>37 wks with mild PE
> 34 wks with severe PE
< 34 wks with any of
 maternal or fetal Distress
 Severe IUGR
 HELLP syndrome
 Pulm. Edema
 Deranged LFT/RFT
 Uncontrolled B/P despite Appropriate drugs
 Imminent eclampsia
Steroid
All pts with severe PE < 34 wks
prevent RDS, treatment of thrombocytopenia
Intrapartum care
• Maternal – V/S Q 30min
Avoid fluid overload
 input/output every 1 hr
FHR monitor Q 15min or EFM
Shorten 2nd stage labor – Instrumental delivery
Fluid –125ml/hr, U.O.P > 30ml/hr
Active Mx of 3rd Stage
Postpartum
Close follow up & monitor B/P
Anticonvulsant for 24-48 hrs
Eclampsia
Definitionn: Occurrence of seizure or coma in
woman with PE that cannot be attributed to other
cause
Preventable complication of preeclampsia
50% intrapartum
25% antepartum
25% postpartum
Atypical eclampsia
Occurrence of eclampsia before 24 week of GA or
after 7th
postpartal day
Most common last trimester & wide spectrum of Sn
& Sign and symptom ranging from:
Extremely B/P <-- --> minimal B/P
proteinuria 4+ <-- --> No proteinuria (14%)
Generalized edema <-- -->No edema (26%)
Patellar reflex 4+ <-- --> normal reflex
##1st warning sign may be excessive Wt gain
Diagnosis
Features of preeclmpsia
+
Generalized tonic-clonic seizure
Aura
Tonic phase
Clonic phase
Post-ictal comavery brief or even not present
Complications of eclampsia
Known complications of PE
+
• Aspiration and asphyxia
• Trauma
• Preterm seizure
• Fetal distress and asphyxia
• Crebral edema in prolonged or repititive seizure
Managem
ent
Description
General •Airway and oxygenation- put in left lateral position; suction airway, insert airway to
depress tongue and prevent injury, administer oxygen via face mask or endotracheal tube
if in respiratory failure
•Prevent trauma – tongue depressor ; fall accident etc
•Fluid resuscitation if in hemodynamic instability- IV line and fluids
Control
convulsion
Administer anticonvulsants – Magnesium sulphate (first line drug); diazepam ( if
magnesium is not available); phenobarbitone; phenytoin… can also be used if the two are
not available
Control
severe HTN
If BP >160/110 mmHg, use fast acting antihypertensives (hydralazine; labetalol;
diazoxide; sodium nitroprusside) to maintain BP between 140/90-160/110.
Fluid mx Restrict fluid administration to 125ml/hr and monitor input-output including urine
output
Organ
support
If any evidence of organ failure; requires critical care and organ support to maintain
homeostasis
Delivery After the above measures are taken and patient is stabilized; pregnancy should be
terminated by the most appropriate route. No conservative Mx !
Prognosis
Reading assignment
effect of preeclampsia-eclampsia syndrome for
future pregnancy
DDX All pregnant women & convulsion should be
considered Eclampsia till other cause R/O
 Epilepsy - encephalitis, meningitis
Cerebral malaria - cerebral tumor
Hypertensive encephalopathy
References
1. Williams obstetrics, 24th
edition
2. Normal and problematic pregnancy, Gabbe, 6th
edition
3. Uptodate 21.6
4. Management protocol on sstetric case, FMOH,
january, 2010
Quize
1. Define severe preeclampsia(2 points)
2. Mention at least four risk factors for preeclampsia.
(2 points)
3. List the two common theories incriminated in
preeclampsia(2 points)
4. How do you define proteinuria in preeclampsia(2
points)
5. What is the preferred drug for seizure
prophylaxis(1 point)
6. What is the definative mx for preeclampsia(1 point)
 THANK YOU

More Related Content

What's hot

PLACENTA ACCRETA SPECTRUM DISORDERS.pptx
PLACENTA ACCRETA SPECTRUM DISORDERS.pptxPLACENTA ACCRETA SPECTRUM DISORDERS.pptx
PLACENTA ACCRETA SPECTRUM DISORDERS.pptx
Niranjan Chavan
 
PLACENTA ACCRETA
PLACENTA ACCRETAPLACENTA ACCRETA
PLACENTA ACCRETA
paviarun
 
HELLP syndrome
HELLP syndromeHELLP syndrome
HELLP syndrome
Ahmed Mowafy
 
Bleeding in Early Pregnancy
Bleeding in Early PregnancyBleeding in Early Pregnancy
Bleeding in Early Pregnancy
limgengyan
 
Hypertensive disorder in pregnancy
Hypertensive disorder in pregnancy Hypertensive disorder in pregnancy
Hypertensive disorder in pregnancy
Md Shahid Iqubal
 
Cervical stitches
Cervical stitchesCervical stitches
Cervical stitches
muhammad al hennawy
 
Female sterilisation
Female sterilisationFemale sterilisation
Female sterilisation
Labeeb Pc
 
Rupture uterus
Rupture uterusRupture uterus
Rupture uterus
muhammad al hennawy
 
Renal transplantation and pregnancy
Renal transplantation and pregnancyRenal transplantation and pregnancy
Renal transplantation and pregnancy
Salwa Ibrahim
 
Induction of labour
Induction of labourInduction of labour
Induction of labour
ArunSharma10
 
Postpartum Haemorrhage : Case Illustration
Postpartum Haemorrhage : Case IllustrationPostpartum Haemorrhage : Case Illustration
Postpartum Haemorrhage : Case Illustration
limgengyan
 
evidence base steps hysterectomy
evidence base steps hysterectomyevidence base steps hysterectomy
evidence base steps hysterectomy
pogisurabaya
 
Cardiotocography (CTG) warda
Cardiotocography (CTG) wardaCardiotocography (CTG) warda
Cardiotocography (CTG) warda
Osama Warda
 
Antepartum Hemorrhage(APH)
Antepartum Hemorrhage(APH) Antepartum Hemorrhage(APH)
Antepartum Hemorrhage(APH)
محمد کاکەبرا
 
Prelabour Rupture of Membrane (PROM) by Sunil Kumar Daha
Prelabour Rupture of Membrane (PROM) by Sunil Kumar DahaPrelabour Rupture of Membrane (PROM) by Sunil Kumar Daha
Prelabour Rupture of Membrane (PROM) by Sunil Kumar Daha
sunil kumar daha
 
Pre eclampsia geet 11
Pre eclampsia geet 11Pre eclampsia geet 11
Pre eclampsia geet 11
Gitanjali Kumari
 
Preeclampsia Revised
Preeclampsia  RevisedPreeclampsia  Revised
Preeclampsia Revised
Aboubakr Elnashar
 
Obstetric antiphospholipid antibody syndrome
Obstetric antiphospholipid  antibody syndrome Obstetric antiphospholipid  antibody syndrome
Obstetric antiphospholipid antibody syndrome
Aboubakr Elnashar
 
Hypertension in pregnancy ( Preeclampsia ) : recent guidelines
Hypertension in  pregnancy ( Preeclampsia ) : recent guidelinesHypertension in  pregnancy ( Preeclampsia ) : recent guidelines
Hypertension in pregnancy ( Preeclampsia ) : recent guidelines
Omar Khaled
 

What's hot (20)

PLACENTA ACCRETA SPECTRUM DISORDERS.pptx
PLACENTA ACCRETA SPECTRUM DISORDERS.pptxPLACENTA ACCRETA SPECTRUM DISORDERS.pptx
PLACENTA ACCRETA SPECTRUM DISORDERS.pptx
 
PLACENTA ACCRETA
PLACENTA ACCRETAPLACENTA ACCRETA
PLACENTA ACCRETA
 
HELLP syndrome
HELLP syndromeHELLP syndrome
HELLP syndrome
 
Bleeding in Early Pregnancy
Bleeding in Early PregnancyBleeding in Early Pregnancy
Bleeding in Early Pregnancy
 
Hypertensive disorder in pregnancy
Hypertensive disorder in pregnancy Hypertensive disorder in pregnancy
Hypertensive disorder in pregnancy
 
Cervical stitches
Cervical stitchesCervical stitches
Cervical stitches
 
Female sterilisation
Female sterilisationFemale sterilisation
Female sterilisation
 
Rupture uterus
Rupture uterusRupture uterus
Rupture uterus
 
Renal transplantation and pregnancy
Renal transplantation and pregnancyRenal transplantation and pregnancy
Renal transplantation and pregnancy
 
Induction of labour
Induction of labourInduction of labour
Induction of labour
 
Postpartum Haemorrhage : Case Illustration
Postpartum Haemorrhage : Case IllustrationPostpartum Haemorrhage : Case Illustration
Postpartum Haemorrhage : Case Illustration
 
evidence base steps hysterectomy
evidence base steps hysterectomyevidence base steps hysterectomy
evidence base steps hysterectomy
 
Cardiotocography (CTG) warda
Cardiotocography (CTG) wardaCardiotocography (CTG) warda
Cardiotocography (CTG) warda
 
Antepartum Hemorrhage(APH)
Antepartum Hemorrhage(APH) Antepartum Hemorrhage(APH)
Antepartum Hemorrhage(APH)
 
Prelabour Rupture of Membrane (PROM) by Sunil Kumar Daha
Prelabour Rupture of Membrane (PROM) by Sunil Kumar DahaPrelabour Rupture of Membrane (PROM) by Sunil Kumar Daha
Prelabour Rupture of Membrane (PROM) by Sunil Kumar Daha
 
Post Caesarian Pregnancy
 Post Caesarian Pregnancy  Post Caesarian Pregnancy
Post Caesarian Pregnancy
 
Pre eclampsia geet 11
Pre eclampsia geet 11Pre eclampsia geet 11
Pre eclampsia geet 11
 
Preeclampsia Revised
Preeclampsia  RevisedPreeclampsia  Revised
Preeclampsia Revised
 
Obstetric antiphospholipid antibody syndrome
Obstetric antiphospholipid  antibody syndrome Obstetric antiphospholipid  antibody syndrome
Obstetric antiphospholipid antibody syndrome
 
Hypertension in pregnancy ( Preeclampsia ) : recent guidelines
Hypertension in  pregnancy ( Preeclampsia ) : recent guidelinesHypertension in  pregnancy ( Preeclampsia ) : recent guidelines
Hypertension in pregnancy ( Preeclampsia ) : recent guidelines
 

Similar to Hypertensive disorder of pregnancy

Pregnancy induced hypertension
Pregnancy induced hypertensionPregnancy induced hypertension
Pregnancy induced hypertensionDeepa Sinha
 
Hypertensive disorders in pregnancy
Hypertensive disorders in pregnancyHypertensive disorders in pregnancy
Hypertensive disorders in pregnancy
nandita Sr. Sarah
 
Htninpregnancy 130120114747-phpapp01
Htninpregnancy 130120114747-phpapp01Htninpregnancy 130120114747-phpapp01
Htninpregnancy 130120114747-phpapp01
Krupa Meet Patel
 
Medical disorders in pregnancy
Medical disorders in pregnancyMedical disorders in pregnancy
Medical disorders in pregnancy
Awoke Worku
 
Pih ppt
Pih pptPih ppt
Pre eclampsia & eclampsia
Pre eclampsia & eclampsiaPre eclampsia & eclampsia
Pre eclampsia & eclampsia
shanza aurooj
 
htninpregnancy-130120114747-phpapp01.pdf
htninpregnancy-130120114747-phpapp01.pdfhtninpregnancy-130120114747-phpapp01.pdf
htninpregnancy-130120114747-phpapp01.pdf
SavitaHanamsagar
 
Hypertensive disorders in pregnancy
Hypertensive disorders in pregnancyHypertensive disorders in pregnancy
Hypertensive disorders in pregnancy
bismoy mondal
 
PIH.pptx8888888888888888888888888888888888
PIH.pptx8888888888888888888888888888888888PIH.pptx8888888888888888888888888888888888
PIH.pptx8888888888888888888888888888888888
JamesAmaduKamara
 
Hellp syndrome
Hellp syndromeHellp syndrome
Hellp syndrome
AlkaPandey24
 
CIP.pptx
CIP.pptxCIP.pptx
CIP.pptx
Priyanka964777
 
hypertension new.pptx
hypertension new.pptxhypertension new.pptx
hypertension new.pptx
VenoshaGunasekaran
 
*Hypertensivedisordersinpregnancy
*Hypertensivedisordersinpregnancy*Hypertensivedisordersinpregnancy
*Hypertensivedisordersinpregnancy
Dr Malleswar Rao Kasina
 
Hypertensive disorders in pregnancy dr. betha fe m. castillo 102413
Hypertensive disorders in pregnancy   dr. betha fe m. castillo 102413Hypertensive disorders in pregnancy   dr. betha fe m. castillo 102413
Hypertensive disorders in pregnancy dr. betha fe m. castillo 102413Jesart De Vera
 
Pregnancy Induced Hypertension
Pregnancy Induced HypertensionPregnancy Induced Hypertension
Pregnancy Induced Hypertension
Ayshwarya Revadkar
 
Hypertensive disorder of pregnancy.pdf
Hypertensive disorder of pregnancy.pdfHypertensive disorder of pregnancy.pdf
Hypertensive disorder of pregnancy.pdf
ahmedhassan756265
 
Hypertensive disorders in Pregnancy
Hypertensive disorders in PregnancyHypertensive disorders in Pregnancy
Hypertensive disorders in Pregnancy
Hanifullah Khan
 
Gestational hypertension
Gestational hypertensionGestational hypertension
Gestational hypertension
University of Florida
 
P R E G N A N C Y I N D U C E D H Y P E R T E N S I O N
P R E G N A N C Y  I N D U C E D  H Y P E R T E N S I O NP R E G N A N C Y  I N D U C E D  H Y P E R T E N S I O N
P R E G N A N C Y I N D U C E D H Y P E R T E N S I O NDr. Shaheer Haider
 
Preeclampsia
PreeclampsiaPreeclampsia
Preeclampsia
Khayyam Macadato
 

Similar to Hypertensive disorder of pregnancy (20)

Pregnancy induced hypertension
Pregnancy induced hypertensionPregnancy induced hypertension
Pregnancy induced hypertension
 
Hypertensive disorders in pregnancy
Hypertensive disorders in pregnancyHypertensive disorders in pregnancy
Hypertensive disorders in pregnancy
 
Htninpregnancy 130120114747-phpapp01
Htninpregnancy 130120114747-phpapp01Htninpregnancy 130120114747-phpapp01
Htninpregnancy 130120114747-phpapp01
 
Medical disorders in pregnancy
Medical disorders in pregnancyMedical disorders in pregnancy
Medical disorders in pregnancy
 
Pih ppt
Pih pptPih ppt
Pih ppt
 
Pre eclampsia & eclampsia
Pre eclampsia & eclampsiaPre eclampsia & eclampsia
Pre eclampsia & eclampsia
 
htninpregnancy-130120114747-phpapp01.pdf
htninpregnancy-130120114747-phpapp01.pdfhtninpregnancy-130120114747-phpapp01.pdf
htninpregnancy-130120114747-phpapp01.pdf
 
Hypertensive disorders in pregnancy
Hypertensive disorders in pregnancyHypertensive disorders in pregnancy
Hypertensive disorders in pregnancy
 
PIH.pptx8888888888888888888888888888888888
PIH.pptx8888888888888888888888888888888888PIH.pptx8888888888888888888888888888888888
PIH.pptx8888888888888888888888888888888888
 
Hellp syndrome
Hellp syndromeHellp syndrome
Hellp syndrome
 
CIP.pptx
CIP.pptxCIP.pptx
CIP.pptx
 
hypertension new.pptx
hypertension new.pptxhypertension new.pptx
hypertension new.pptx
 
*Hypertensivedisordersinpregnancy
*Hypertensivedisordersinpregnancy*Hypertensivedisordersinpregnancy
*Hypertensivedisordersinpregnancy
 
Hypertensive disorders in pregnancy dr. betha fe m. castillo 102413
Hypertensive disorders in pregnancy   dr. betha fe m. castillo 102413Hypertensive disorders in pregnancy   dr. betha fe m. castillo 102413
Hypertensive disorders in pregnancy dr. betha fe m. castillo 102413
 
Pregnancy Induced Hypertension
Pregnancy Induced HypertensionPregnancy Induced Hypertension
Pregnancy Induced Hypertension
 
Hypertensive disorder of pregnancy.pdf
Hypertensive disorder of pregnancy.pdfHypertensive disorder of pregnancy.pdf
Hypertensive disorder of pregnancy.pdf
 
Hypertensive disorders in Pregnancy
Hypertensive disorders in PregnancyHypertensive disorders in Pregnancy
Hypertensive disorders in Pregnancy
 
Gestational hypertension
Gestational hypertensionGestational hypertension
Gestational hypertension
 
P R E G N A N C Y I N D U C E D H Y P E R T E N S I O N
P R E G N A N C Y  I N D U C E D  H Y P E R T E N S I O NP R E G N A N C Y  I N D U C E D  H Y P E R T E N S I O N
P R E G N A N C Y I N D U C E D H Y P E R T E N S I O N
 
Preeclampsia
PreeclampsiaPreeclampsia
Preeclampsia
 

More from Engidaw Ambelu

pop andurinary incontinence
pop andurinary incontinencepop andurinary incontinence
pop andurinary incontinence
Engidaw Ambelu
 
Congenital heart disease
Congenital heart diseaseCongenital heart disease
Congenital heart disease
Engidaw Ambelu
 
PROM
PROMPROM
preterm labor
preterm laborpreterm labor
preterm labor
Engidaw Ambelu
 
postpartum hemorrhage
postpartum hemorrhagepostpartum hemorrhage
postpartum hemorrhage
Engidaw Ambelu
 
antepartal hemorrhage
antepartal hemorrhageantepartal hemorrhage
antepartal hemorrhage
Engidaw Ambelu
 
acquired heart disease
acquired heart diseaseacquired heart disease
acquired heart disease
Engidaw Ambelu
 
congenital heart disease_january2011_final
congenital heart disease_january2011_finalcongenital heart disease_january2011_final
congenital heart disease_january2011_final
Engidaw Ambelu
 
CNS infections
CNS infectionsCNS infections
CNS infections
Engidaw Ambelu
 
Seizure disorders
Seizure disordersSeizure disorders
Seizure disorders
Engidaw Ambelu
 
urinary tract infection
urinary tract infectionurinary tract infection
urinary tract infection
Engidaw Ambelu
 
Approach to the child with anemia
Approach to the child with anemiaApproach to the child with anemia
Approach to the child with anemia
Engidaw Ambelu
 
Childhood asthma & TB
Childhood asthma & TBChildhood asthma & TB
Childhood asthma & TB
Engidaw Ambelu
 
Seminar on poisoning
Seminar on poisoningSeminar on poisoning
Seminar on poisoning
Engidaw Ambelu
 
Diarrheal diseases in children
Diarrheal diseases  in childrenDiarrheal diseases  in children
Diarrheal diseases in children
Engidaw Ambelu
 
Abnormal labor
Abnormal laborAbnormal labor
Abnormal labor
Engidaw Ambelu
 
Bibl study power point aragaw final
Bibl study power point aragaw finalBibl study power point aragaw final
Bibl study power point aragaw final
Engidaw Ambelu
 
Acute respiratory tract infections
Acute respiratory tract infectionsAcute respiratory tract infections
Acute respiratory tract infections
Engidaw Ambelu
 
Approach to childhood poisoning.tmp 12
Approach to childhood poisoning.tmp 12Approach to childhood poisoning.tmp 12
Approach to childhood poisoning.tmp 12
Engidaw Ambelu
 
Labor
LaborLabor

More from Engidaw Ambelu (20)

pop andurinary incontinence
pop andurinary incontinencepop andurinary incontinence
pop andurinary incontinence
 
Congenital heart disease
Congenital heart diseaseCongenital heart disease
Congenital heart disease
 
PROM
PROMPROM
PROM
 
preterm labor
preterm laborpreterm labor
preterm labor
 
postpartum hemorrhage
postpartum hemorrhagepostpartum hemorrhage
postpartum hemorrhage
 
antepartal hemorrhage
antepartal hemorrhageantepartal hemorrhage
antepartal hemorrhage
 
acquired heart disease
acquired heart diseaseacquired heart disease
acquired heart disease
 
congenital heart disease_january2011_final
congenital heart disease_january2011_finalcongenital heart disease_january2011_final
congenital heart disease_january2011_final
 
CNS infections
CNS infectionsCNS infections
CNS infections
 
Seizure disorders
Seizure disordersSeizure disorders
Seizure disorders
 
urinary tract infection
urinary tract infectionurinary tract infection
urinary tract infection
 
Approach to the child with anemia
Approach to the child with anemiaApproach to the child with anemia
Approach to the child with anemia
 
Childhood asthma & TB
Childhood asthma & TBChildhood asthma & TB
Childhood asthma & TB
 
Seminar on poisoning
Seminar on poisoningSeminar on poisoning
Seminar on poisoning
 
Diarrheal diseases in children
Diarrheal diseases  in childrenDiarrheal diseases  in children
Diarrheal diseases in children
 
Abnormal labor
Abnormal laborAbnormal labor
Abnormal labor
 
Bibl study power point aragaw final
Bibl study power point aragaw finalBibl study power point aragaw final
Bibl study power point aragaw final
 
Acute respiratory tract infections
Acute respiratory tract infectionsAcute respiratory tract infections
Acute respiratory tract infections
 
Approach to childhood poisoning.tmp 12
Approach to childhood poisoning.tmp 12Approach to childhood poisoning.tmp 12
Approach to childhood poisoning.tmp 12
 
Labor
LaborLabor
Labor
 

Recently uploaded

A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
Mohammed Sikander
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
deeptiverma2406
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
chanes7
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 

Recently uploaded (20)

A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 

Hypertensive disorder of pregnancy

  • 1. HYPERTENSIVE DISORDERS IN PREGNANCY GIRMACHEW T.(MD) OBGY MAY 22, 2018 GONDAR, ETHIOPIA
  • 2. Outline Diagnosis of HTN Introduction Classification Pathophysiology and risk factor Clinical presentation Management
  • 3. Introduction  Most common medical complication  Incidence 7-10% all pregnancies 70 % Preeclampsia- Eclampsia 30 % Chronic HTN 0.05 Eclamosia  Major cause of maternal and perinatal mortality & morbidity.
  • 4. Classification 1) Gestational HTN( transient HTN) 2) Preeclampsia- Eclampsia syndrome 3) Chronic HTN 4) Preeclampsia superimposed on chronic HTN
  • 5. Diagnosis Hypertension: Systolic BP > 140 or DBP > 90 mmHg. Measured on any two occasions > 6hrs apart or One DBP> 110 mmHg
  • 6. Proteinuria Urine protein > 300mg/24hr or 30mg/dl(1+dipstick) or 0.1gm/L in at least two random urine sample Urine protein : creatinine ratio > 0.3 Edema No longer part of diagnosis * wt gain >1kg/ week & pathological edema are↑ warning sign
  • 7. Gestational Hypertension Definition B/P > 140/90 mmHg for first time during pregnancy after 20 wks G.A or first 24 hrs post partum.  No proteinuia  Mild HPN & must return with in 12 weeks postpartum  It is a diagnosis of exclusion  Final dx made only postpartum. Pregnancy outcome similar to normotensive pregn
  • 8.  At risk of progression to PE or eclampsia  Close observation of maternal & fetal condition  In absence of severe HPN or PE can continue pregnancy till term
  • 9. Preeclampsia Definition  new onset of hypertension after 20 weeks of gestation and 1. Proteinuria 2.Trombocytopenia(<100,000/ml) 3.Renal insuficiency….cr>1.2 mg/dl or doubling of base line 4.Liver involvement….transaminase elivation 5.Cerebral symptoms…headache, visual disturbance, convulsion 6.Pulmonary edema
  • 10.  pregnancy specific syndrome of reduced organ perfusion secondary to vasospasm and endothelial activation. incidence nullipara = 3-7% multipara 0.8-5%
  • 11. Superimposed upon chronic HTN HTN and no proteinuria <20 weeks:  New onset proteinuria after 20 weeks of GA HTN and protienuria <20 weeks: Sudden increase in proteinuria Sudden increase in BP in woman whose BP was well controlled Thrombocytopenia ( <100,000/ml) Increase in ALT or AST to abnormal levels
  • 12. Chronic HTN BP > 140/90 mmhg before px or diagnosed before 20 weeks of GA or diagnosed after 20 weeks of GA and persists after 12 weeks postpartum Other associated findings  Retinal change  Cardiac  Renal diseaese  Other medical illness
  • 13. Risk factors for PE • Nulliparity • Obesity • Age <20 or > 35 yrs(chronic HTN and superimposed PE) • Multiple gestation • Low socioeconomic status • GTD • Poor outcome of previous pregnancy (IUGR, SB ,abruption) • ART( assisted reproductive technology) • Race , ethinicity, genetics
  • 14. Pre-existing medical conditions  Chronic HTN  Renal disease  DM (type I)  Thrombophilias (APA, protein C,S deficiency ) Smoking is it a risk factor or protective?
  • 15. Classification of PE Non severe PE Severe PE BP >160/110 mmhg Proteinuria of >5g/24 hr Oliguria <500ml/24 hrs Thrombocytopenia Elivated liver function test with persistent epigastric or RUQ pain Pulmonary edema Persistent severe cerebral or visual disturbances Convulsion HELLP syndrome and DIC BP >140/90 mmhg Proteinuria of 300mg/ 24 hrs or 1+ on dipstich
  • 16.
  • 17. Etiology & pathogenesis Etiology – Unknown Known as disease of theory Some of theories • Abnormal trophoblast invasion Coagulation Abnormalties Vascular endothelial damage Immunologic theory Placental toxin theory……toxemia of pregnancy Genetic predisposition Dietary deficiencies ….calcium and antioxidant deficiencies
  • 18. Any theory has the following charactersitics 1. Exposed to chorionic villi for the first time….nulliparous 2.Exposed to superabundance of chorionic villi…twins and GTD 3.Preexisting condition of endothelial cell activation/inflammation….DM/renal/ cardiovascular disease 4.Genetically predisposed to HTN developing during pregnancy…family hx
  • 19. Abnormal Trophoblast invasion Defective vascular response to placentation due to inhibition of 2nd wave of endovascular trophoblast occur often 16 week
  • 20. Trophoblastic invasion of spiral arterioles leads to the destruction of the muscularis layer which is replaced by trophoblastic cells which do not respond to the autonomic stimulation of blood vessels; this ensures that there is a constant uninterrupted blood flow to the intervillous space
  • 21. According to the immunological theory, there is sufficient similarity between paternal and maternal HLA antigens, which prevents early fetal antigens from detection by the maternal immune system This leads to failure of production of blocking antibodies early in gestation As fetal antigens increase in amount later in gestation, the maternal immune system responds by producing antibodies that destroy placental trophoblasts
  • 22. SYSTEMIC ENDOTHELIAL DYSFUNCTION All of the clinical features of preeclampsia can be explained as maternal responses to generalized endothelial dysfunction Disturbed endothelial control of vascular tone causes hypertension, increased vascular permeability results in edema and proteinuria, and abnormal endothelial expression of procoagulants leads to coagulopathy. These changes also cause ischemia of target organs, such as the brain, liver, kidney, and placenta.
  • 23. Laboratory evidence supporting generalized endothelial dysfunction in preeclamptic women - Decreased production of endothelial-derived vasodilators -nitric oxide and prostacyclin - increased production of vasoconstrictors -endothelins and thromboxanes. - Enhanced vascular reactivity to angiotensin II
  • 24. Organ system Pathology complication CVS Generalized vasospasm; increased afterload; left ventricular strain and failure; microvascular endothelial damage and fluid and protein leakage •Hypertension •Congestive heart failure •Generalized edema •Pulmonary edema Hematolog ic Excessive consumption of platelets to repair endothelial damage; RBC damage as they pass through the spastic arterioles •Thrombocytopenia •Microangiopathic hemolytic anemia Renal Decreased glomerular filtration rate due to spasm; renal glomerulo endotheliosis; renal tubular necrosis; renal cortical necrosis in advanced •Acute renal failure •Proteinuria •Hyperuricemia Respirator y Pulmonary capillary endothelial damage and leakage ( in addition to hypoproteinemia due to proteinuria and left ventricular failure) Pulmonary edema
  • 25. Organ system pathology complication Gastrointes tinal Hepatocellular injury distal to vascular spasm site; focal hemorrhages distal to spasm site; coalescing focal hemorrhages leading to large hematoma collection under the Glisson’s capsule •Hepatic failure •Sub capsular hematoma •Acute liver rupture CNS Cerebral hypoxia due to vasospasm; focal hemorrhages distal to the vasospasm; secondary cerebral edema; intracranial hemorrhages •Eclampsia •Hemorrhagic stroke •Cerebral edema and death due to coning •Transient blindness – retinal or cortical HELLP syndrome Concomitant occurrence of microangiopathic hemolysis; thrombocytopenia and liver damage features in a woman with preeclampsia
  • 26. system pathology complication Blood volume Due to generalized vasospasm, there is contracture of the total vascular space. The normal increase in blood volume that occurs during normal pregnancy fails in preeclampsia. They tend to have a contracted and overall reduced blood volume •Less tolerant to blood loss at delivery with an easy propensity to post partum hemmorhage with small amount of blood loss •Less tolerant to fluid administration with a propensity to develop pulmonary edema
  • 27. symptoms sign Diagnostic study •Non severe preeclampsia is asymptomatic •Symptoms are late features indicating severe disease or imminent risk of convulsions •These symptoms include headache, blurring of vision, epigastric pain, oliguria and generalized body swelling •Hypertension •Generalized edema/anasarca •Excessive weight gain •Exaggerated deep tendon reflexes •Proteinuria •24 hour urine for proteinuria •Liver and renal function tests •Hematocrit •Peripheral blood smear for shistocytes (fragmented RBC) •Platelet count •Serum uric acid measurement •Fetal well being studies As preeclampsia is asymptomatic until it progresses to severe stages, detection and diagnosis requires active screening of all pregnant women during antenatal care. Routine blood pressure measurements, weight gain surveillance and check for symptoms and proteinuria are performed to detect preeclampsia early.
  • 28. Management Objective Preserve health of mother & fetus Prevent progression to eclampsia Delivery of alive, mature fetus * Once Dx is made definitive Rx is delivery * Precise Knowledge G.A Important for Mx. Mx of Non severe PE Hospitalization  at time of Dx Purpose Evaluate maternal & fetal condition
  • 29. Hospital Mx Maternal follow up  Weight on admn. & every other day  B/P  Q 4 hrly  Daily clinical Hx premonitory Sx  Urine protein every 48 hrs Hct, Plc, RFT, LFT, uric Acid, coagulation profile weekly or 2x/week.
  • 30. Fetal evaluation Daily FHR Auscultation & fetal mov’t count Fetal growth: clinical & U/Sound Well being NST/BPP (2x/week) **Non sevre PE remote from term delivery at term but pregnancy should not pass 40 weeks. ** no need of antihypertensive or seizure prophylaxix
  • 31. Mx of severe PE characterized by progressive deterioration of both maternal & fetal condition  All should be delivered if disease develope >34 week G.A or prior to 34 weeks if there is - Maternal (Fetal) distress - Labor or PROM - Severe IUGR **Delivery should be based on maternal and fetal conditions as well as GA
  • 32. Mx of severe PE includes Maternal & fetal evaluation same Non PE but more frequent. Anticonvulsant to prevent convulsion Antihypertensive To control B/P in safe range Induction of labor Delivery  Admit to labor & delivery area.  Then Maternal & fetal evaluation 1st 24 hr  Anti-convulsant  parenteral route To prevent seizure
  • 33.
  • 34. Indication Anti- convulsant drugs  Mg so4  Diazepam  Phenytoin
  • 35. Antepartum mg't of severe PE Magnesium Sulfate (Mg So4) Mg so4 Agent of choice for seizure prophylaxis Dose: loading dose 4gm 20%soln  over 10-15min followed by 10 g of 50% solution half on each buttock maintenance dose: 5gmI.M/4 hr Make sure the following before giving next dose 1. Patellar reflex is present 2.RR at least 16 breaths/min 3. UOP of previous 4 hr exceeded 100 ml Side effect: Weakness, paralysis, cardiac toxicity Monitor: RR, DTR,Level of consciousness, UOP Antidote: Calcium gluconate 10 ml of 10% I.V
  • 36. MgSO4 level (mg/dl) 4.8- 8.4 8- 10 12 -17 13- 17 19 -20 Effects Therapeutic level Loss of DTR Respiratory depression CNS depression, coma Cardiac arrest Clinical effects are related directly to plasma levels
  • 37. Antihypertensive  If DBP > 110 mmHg Acute Rx Arteriolar dilators – Hydralazine 5mg iv then 5-10mg Q 20min. B- Blocker – labetalol Ca channel blocker – nifedipine
  • 38. Maintenance Rx Centrally acting  Methyl dopa B- Blockers- labetalol Ca channel Blocker -nefidipine ACE inhibitors C/I in pregnancy
  • 39. Delivery PE progressive disease Timely delivery  decreases maternal and fetal morbidity& mortality Stabilize maternal status before Delivery Route of delivery…vaginal delivery is preferable
  • 40. Indication to Delivery in PE >37 wks with mild PE > 34 wks with severe PE < 34 wks with any of  maternal or fetal Distress  Severe IUGR  HELLP syndrome  Pulm. Edema  Deranged LFT/RFT  Uncontrolled B/P despite Appropriate drugs  Imminent eclampsia
  • 41. Steroid All pts with severe PE < 34 wks prevent RDS, treatment of thrombocytopenia Intrapartum care • Maternal – V/S Q 30min Avoid fluid overload  input/output every 1 hr FHR monitor Q 15min or EFM Shorten 2nd stage labor – Instrumental delivery Fluid –125ml/hr, U.O.P > 30ml/hr Active Mx of 3rd Stage
  • 42. Postpartum Close follow up & monitor B/P Anticonvulsant for 24-48 hrs
  • 43. Eclampsia Definitionn: Occurrence of seizure or coma in woman with PE that cannot be attributed to other cause Preventable complication of preeclampsia 50% intrapartum 25% antepartum 25% postpartum Atypical eclampsia Occurrence of eclampsia before 24 week of GA or after 7th postpartal day
  • 44. Most common last trimester & wide spectrum of Sn & Sign and symptom ranging from: Extremely B/P <-- --> minimal B/P proteinuria 4+ <-- --> No proteinuria (14%) Generalized edema <-- -->No edema (26%) Patellar reflex 4+ <-- --> normal reflex ##1st warning sign may be excessive Wt gain
  • 45. Diagnosis Features of preeclmpsia + Generalized tonic-clonic seizure Aura Tonic phase Clonic phase Post-ictal comavery brief or even not present
  • 46. Complications of eclampsia Known complications of PE + • Aspiration and asphyxia • Trauma • Preterm seizure • Fetal distress and asphyxia • Crebral edema in prolonged or repititive seizure
  • 47. Managem ent Description General •Airway and oxygenation- put in left lateral position; suction airway, insert airway to depress tongue and prevent injury, administer oxygen via face mask or endotracheal tube if in respiratory failure •Prevent trauma – tongue depressor ; fall accident etc •Fluid resuscitation if in hemodynamic instability- IV line and fluids Control convulsion Administer anticonvulsants – Magnesium sulphate (first line drug); diazepam ( if magnesium is not available); phenobarbitone; phenytoin… can also be used if the two are not available Control severe HTN If BP >160/110 mmHg, use fast acting antihypertensives (hydralazine; labetalol; diazoxide; sodium nitroprusside) to maintain BP between 140/90-160/110. Fluid mx Restrict fluid administration to 125ml/hr and monitor input-output including urine output Organ support If any evidence of organ failure; requires critical care and organ support to maintain homeostasis Delivery After the above measures are taken and patient is stabilized; pregnancy should be terminated by the most appropriate route. No conservative Mx !
  • 48. Prognosis Reading assignment effect of preeclampsia-eclampsia syndrome for future pregnancy
  • 49. DDX All pregnant women & convulsion should be considered Eclampsia till other cause R/O  Epilepsy - encephalitis, meningitis Cerebral malaria - cerebral tumor Hypertensive encephalopathy
  • 50. References 1. Williams obstetrics, 24th edition 2. Normal and problematic pregnancy, Gabbe, 6th edition 3. Uptodate 21.6 4. Management protocol on sstetric case, FMOH, january, 2010
  • 51. Quize 1. Define severe preeclampsia(2 points) 2. Mention at least four risk factors for preeclampsia. (2 points) 3. List the two common theories incriminated in preeclampsia(2 points) 4. How do you define proteinuria in preeclampsia(2 points) 5. What is the preferred drug for seizure prophylaxis(1 point) 6. What is the definative mx for preeclampsia(1 point)